LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under SEBI's Listing Regulations. The report, issued by Chandrasekaran Associates, Company Secretaries, reviews the company's compliance with SEBI regulations, secretarial standards, and corporate governance norms. All 12 compliance parameters checked — including secretarial standards, policy adoption, website disclosures, director eligibility, related party transactions, insider trading, and event disclosures — are marked as compliant. There are no material subsidiaries, no auditor resignation during the period, no prior observations to remediate, and no actions taken by SEBI or the stock exchanges against the company.
This is a routine annual regulatory filing confirming clean compliance with SEBI rules. It carries no material business impact and is unlikely to affect the stock price.